The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
November 21st 2024
Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Report from ARRS: Breast MRI CAD zeroes in on malignancies
April 17th 2008Computer-aided detection schemes for breast MR imaging have shown plenty of promise, but they always fall short of full automation and lesion characterization. Two recent studies, however, suggest CAD for breast MRI may be closing in on true cancer detection.
NSF lawsuit discovery process may expose lax contrast documentation
April 16th 2008A casual attitude toward keeping track of gadolinium-enhanced studies may come back to haunt radiology departments that have become involved in several federal lawsuits alleging a connection between cases of nephrogenic systemic fibrosis and gadolinium-based MR contrast agents.
Scientific abstracts indicate growing prestige of ARRS annual meeting
April 15th 2008What’s happening with the American Roentgen Ray Society? Its annual meeting, known mainly for the quality of its refresher course, has become an essential point of coverage for world-class scientific research as well.
Florida radiologist agrees to pay $7 million to resolve kickback claims
April 15th 2008Dr. Fred L. Steinberg and his imaging centers and related entities in Palm Beach County near Miami will pay $7 million to settle alleged violations of federal Stark self-referral law and anti-kickback statutes. He was also charged with billing fraud.
Report from ARRS: Study establishes infection as NSF risk factor
April 14th 2008New evidence has surfaced pinpointing specific potential causes of nephrogenic systemic fibrosis. Findings sustain its relationship to some gadolinium-based contrast media, but they also suggest that infection, certain patient demographics, and even some drugs could be strongly associated with the condition.
Proton MRS links fibromyalgia pain to changes in brain molecule
April 10th 2008Widespread muscle and tissue pain, tenderness, and fatigue are well-documented symptoms of fibromyalgia, a chronic condition that affects up to an estimated 6% of the U.S. population. The underlying pathology of the pain disease is unknown. A new study featuring proton MR spectroscopy, however, has found a key linkage between the pain and a specific brain molecule.
New recommendations target NSF risk
April 2nd 2008Nephrogenic systemic fibrosis has received widespread attention, but official protocols on how to avoid the life-threatening skin condition are quite sparse: Only one section in the American College of Radiology’s 2007 white paper on safe MR practices is devoted to the condition.
Imaging modalities shed light on intracranial cysts
Any fluid-filled cavity or sac that is lined by an epithelium is a cyst, and intracranial cystic lesions are a common finding on CT and MR imaging of the brain.1,2 These lesions contain either cerebrospinal fluid, fluid that is similar to CSF, mucus, or proteinaceous fluid. They are lined by epithelial cells, inflammatory cells, or glial cells. The attenuation characteristics of the cyst on CT and MRI and the contrast enhancement patterns depend on the cyst's contents and the composition of the wall.
Report from SIR: Cryotherapy proves long-term effectiveness in primary renal cancer
March 26th 2008Results from two clinical trials demonstrate that cryoablation of renal cell carcinomas is effective at least a year after treatment in nearly all patients with lesions 4 cm or smaller. The studies suggest that cryotherapy could serve as an alternative to surgery.
Panel orders centralized pretrial proceedings in NSF cases
March 20th 2008The discovery process for more than 60 federal lawsuits alleging a connection between cases of nephrogenic systemic fibrosis and gadolinium-based MR contrast agents will be consolidated at a single district court in Ohio, according to a U.S. judicial panel. Centralization will accelerate the discovery process and give plaintiffs access to a wider pool of pretrial information.
MRI unveils hidden cardiac disease in patients with systemic sclerosis
March 13th 2008Cardiac MR imaging with delayed gadolinium enhancement can detect silent myocardial fibrosis and other cardiac abnormalities in patients with systemic sclerosis, German researchers told attendees of a cardiac session in Vienna.
Whole-body cancer staging requires frequent follow-up in some patients
March 12th 2008Whole-body MRI is more sensitive but less specific than FDG-PET/CT for cancer detection, according to researchers from China and Europe. Findings suggest a complementary rather than exclusive role in oncologic imaging for both modalities and validate recent studies suggesting close follow-up since either test can miss metastases.
Report from ECR: Delayed-enhancement MR saves senior marathon runners from lethal lap
March 11th 2008Marathon runners 50 years or older may face a higher than expected risk of sudden cardiovascular accidents. MR imaging with late gadolinium enhancement may help identify these athletes in time to keep them from potentially deadly episodes, according to German researchers reporting at the 2008 European Congress of Radiology in Vienna.
Report from ECR 2008: Delayed-enhancement MR saves senior marathon runners from lethal lap
March 10th 2008Marathon runners 50 years or older may face a higher than expected risk of sudden cardiovascular accidents. MR imaging with late gadolinium enhancement may help identify these athletes in time to keep them from potentially deadly episodes, according to German researchers.
Imaging comes of age in biomedical research
March 10th 2008Radiologists must develop strategies for participating in the new age of imaging-based research. They need to join interdisciplinary teams, develop core imaging facilities for host institutions, involve themselves in small-animal imaging facilities, enter clinical research programs, and learn about PET and molecular imaging, which are at the core of pharmaceutical development.
Israel showcases tomorrow’s imaging tools
March 10th 2008Delegates caught a glimpse of the future of radiological technology at Sunday’s “ESR meets Israel” session.Israel may be relatively a small nation, with a population of just seven million, but it is making important contributions to innovation. About 900 companies are developing new pharmaceuticals, medical devices, and healthcare IT products. The majority of these businesses are relatively young and are supported by venture capital funding.